Bend, OR, United States of America

Erica Schlesinger

This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Bend, OR (US) (2023)
  • Sisters, OR (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Erica Schlesinger: Innovator in Biologics and Hydrogels

Introduction

Erica Schlesinger is a prominent inventor based in Bend, OR (US). She has made significant contributions to the field of biologics and hydrogels, holding a total of 3 patents. Her work focuses on enhancing the therapeutic applications of protein formulations through innovative methods.

Latest Patents

One of her latest patents is titled "Tuning of release kinetics in hydrogels." This patent outlines methods for adjusting the release profile of biologics contained within hydrogels. The parameters for tuning include the molar ratio of nucleophilic to electrophilic groups, the number of these groups in the precursors, and the molecular weights of the precursors. These methods enable the creation of hydrogels with varied release profiles, making them suitable for different therapeutic applications. Another significant patent involves the development of high concentration protein formulations, which focuses on the composition and methods for producing therapeutic proteins at high concentrations.

Career Highlights

Erica Schlesinger is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in biologics and hydrogels. Her innovative work has positioned her as a key figure in her field, contributing to the development of new therapeutic solutions.

Collaborations

Throughout her career, Erica has collaborated with notable colleagues, including Hunter Chen and James Feindt. These partnerships have further enriched her research and innovation efforts.

Conclusion

Erica Schlesinger's contributions to the field of biologics and hydrogels demonstrate her commitment to advancing therapeutic applications. Her innovative patents and collaborative efforts highlight her role as a leading inventor in this important area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…